The St. Jude Medical Infinity™ Deep Brain Stimulation (DBS) system with directional lead technology is designed to help patients with Parkinson’s disease or essential tremor gain control of their ...
Abbott Laboratories (NYSE:ABT) received FDA approval to launch the Liberta RC DBS system, the world’s smallest rechargeable deep brain stimulation (DBS) device with remote programming, to treat people ...
European approval introduces the world's only closed-loop DBS system with real-time, self-adjusting brain stimulation for people with Parkinson's disease For 30 years, people with Parkinson's disease ...
Abbott has received U.S. Food & Drug Administration approval to launch a deep brain stimulation system (DBS) that the company touts as the world's smallest rechargeable device of its kind, the medical ...
(RTTNews) - Abbott (ABT) announced the FDA has granted Breakthrough Device Designation to investigate the use of its deep brain stimulation system in treatment-resistant depression. Abbott's DBS ...
The US Food and Drug Administration (FDA) has approved the first adaptive deep brain stimulation (aDBS) system for Parkinson’s disease (PD) that self-adjusts therapy to individual brain activity in ...
Boston Scientific Corporation BSX has received CE Mark approval for use of the GUIDE™ DBS System, the world's first deep brain stimulation (DBS) visualization system. GUIDE DBS provides clinicians ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results